Ganakan, Naisa .

HRN: 27-79-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2025
CEFUROXIME 500MG (TAB)
09/14/2025
09/21/2025
PO
500mg
BID
Sp Nsvd With Rmle
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines